1236 related articles for article (PubMed ID: 25946437)
1. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
2. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
3. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
[TBL] [Abstract][Full Text] [Related]
4. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the U.K. Transcatheter Aortic Valve Implantation Registry.
Duncan A; Ludman P; Banya W; Cunningham D; Marlee D; Davies S; Mullen M; Kovac J; Spyt T; Moat N
JACC Cardiovasc Interv; 2015 Apr; 8(5):645-53. PubMed ID: 25946435
[TBL] [Abstract][Full Text] [Related]
7. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
8. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
Thomas M; Schymik G; Walther T; Himbert D; Lefèvre T; Treede H; Eggebrecht H; Rubino P; Colombo A; Lange R; Schwarz RR; Wendler O
Circulation; 2011 Jul; 124(4):425-33. PubMed ID: 21747054
[TBL] [Abstract][Full Text] [Related]
9. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
[TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary bypass and intra-aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: a PARTNER trial substudy.
Shreenivas SS; Lilly SM; Szeto WY; Desai N; Anwaruddin S; Bavaria JE; Hudock KM; Thourani VH; Makkar R; Pichard A; Webb J; Dewey T; Kapadia S; Suri RM; Xu K; Leon MB; Herrmann HC
Catheter Cardiovasc Interv; 2015 Aug; 86(2):316-22. PubMed ID: 25546704
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
[TBL] [Abstract][Full Text] [Related]
13. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
[TBL] [Abstract][Full Text] [Related]
14. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
[TBL] [Abstract][Full Text] [Related]
15. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients.
Di Mario C; Eltchaninoff H; Moat N; Goicolea J; Ussia GP; Kala P; Wenaweser P; Zembala M; Nickenig G; Alegria Barrero E; Snow T; Iung B; Zamorano P; Schuler G; Corti R; Alfieri O; Prendergast B; Ludman P; Windecker S; Sabate M; Gilard M; Witowski A; Danenberg H; Schroeder E; Romeo F; Macaya C; Derumeaux G; Maggioni A; Tavazzi L;
EuroIntervention; 2013 Apr; 8(12):1362-71. PubMed ID: 23256965
[TBL] [Abstract][Full Text] [Related]
16. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
[TBL] [Abstract][Full Text] [Related]
18. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.
Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J
JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.
Dvir D; Sagie A; Porat E; Assali A; Shapira Y; Vaknin-Assa H; Shafir G; Bental T; Nevzorov R; Battler A; Kornowski R
Catheter Cardiovasc Interv; 2013 Apr; 81(5):871-81. PubMed ID: 22915555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
